Table 1.
Data sets | Sources | Number of calves | Total number of plasma samples | Number of plasma samples < LLOQ | LLOQ mg/L | Range of sampling times (h) after dosing | Products |
---|---|---|---|---|---|---|---|
A | Sidhu et al., 2014 | 10 | 190 | 0 | 0.25 | 0–80 | Nuflor® |
B | Company | 16 | 240 | 12 | 0.05 | 0–192 | Nuflor® |
16 | 240 | 3 | 0.05 | 0–192 | Generic (Norfenicol®) | ||
C | Unpublished | 8 | 200 | 7 | 0.05 | 0–216 | Nuflor® |
Total | 50 | 870 | 22 |
The 10 calves of the Sidhu' paper were healthy female Aberdeen Angus calves weighing 145–204 kg and aged 79–131 days. The 16 European stock calves from Company were 7 males and 9 females, aged ~5–9 months. They were randomly assigned to two treatment groups with 8 animals in each group, in a manner designed to minimize weight differences. All animals were healthy and physiologically normal. Weights ranged from 136 to 205 kg at selection. The eight unpublished calves were Holstein/Fresian cross-breed and weighed from 108 to 165 kg. Data reported as below the Level of Quantification (< BLQ) obtained after the drug administration was low (2.6%) and were ignored in the present analysis.